Yu Yong-qiang, Yang Huai-an, Xiao Ming, Wang Jing-wei, Huang Dong-yan, Bhambhani Yagesh, Sonnenberg Lyn, Clark Brenda, Jin Yuan-zhe, Fu Wei-neng, Zhang Jie, Yu Qian, Liang Xue-ting, Zhang Ming
Chin Med Sci J. 2015 Sep;30(3):179-88. doi: 10.1016/s1001-9294(15)30044-4.
In this article, the mechanism of inheritance behind inherited hearing loss and genetic susceptibility in noise-induced hearing loss are reviewed. Conventional treatments for sensorineural hearing loss (SNHL), i.e. hearing aid and cochlear implant, are effective for some cases, but not without limitations. For example, they provide little benefit for patients of profound SNHL or neural hearing loss, especially when the hearing loss is in poor dynamic range and with low frequency resolution. We emphasize the most recent evidence-based treatment in this field, which includes gene therapy and allotransplantation of stem cells. Their promising results have shown that they might be options of treatment for profound SNHL and neural hearing loss. Although some treatments are still at the experimental stage, it is helpful to be aware of the novel therapies and endeavour to explore the feasibility of their clinical application.
本文综述了遗传性听力损失背后的遗传机制以及噪声性听力损失中的遗传易感性。感音神经性听力损失(SNHL)的传统治疗方法,即助听器和人工耳蜗,对某些病例有效,但并非没有局限性。例如,它们对重度SNHL或神经性听力损失患者益处不大,尤其是当听力损失的动态范围较差且频率分辨率较低时。我们强调该领域最新的循证治疗方法,包括基因治疗和干细胞同种异体移植。它们令人鼓舞的结果表明,它们可能是重度SNHL和神经性听力损失的治疗选择。尽管一些治疗仍处于实验阶段,但了解这些新疗法并努力探索其临床应用的可行性是有帮助的。